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The CVLT-II provides standardized scores for each of the List A ﬁve learning trials, so that the clinician can compare the
patient’s raw trials 1–5 scores with standardized ones. However, frequently, a patient’s raw scores ﬂuctuate making a proper
interpretation diﬃcult. The CVLT-II does not oﬀer any other methods for classifying a patient’s learning and memory status
on the background of the learning curve. The main objective of this research is to illustrate that discriminant analysis provides an
accurate assessment of the learning curve, if suitable predictor variables are selected. Normal controls were ninety-eight healthy
volunteers (78 females and 20 males). A group of MS patients included 365 patients (266 females and 99 males) with clinically
deﬁned multiple sclerosis. We show that the best predictor variables are coeﬃcients B3a n dB4 of our mathematical model
B3 ∗ exp(−B2 ∗ (X − 1)) + B4 ∗ (1 − exp(−B2 ∗ (X − 1))) because discriminant functions, calculated separately for B3
and B4, allow nearly 100% correct classiﬁcation. These predictors allow identiﬁcation of separate impairment of readiness to learn
or ability to learn, or both.
1.Introduction
Multiple sclerosis (MS) is an autoimmune disease of the
centralnervous systemleading todemyelizationandscarring
within the cerebrum and the spinal cord [1, 2]a sw e l la s
gray matter atrophy [3]. Cognitive impairment is among the
main symptoms, aﬀecting about half of all MS patients, and
lower processing speed and defective retrieval from recent
memory storage are frequently observed [4–6]. Impairment
of cognitive functioning is correlated with brain atrophy
revealed with MRI [7, 8]. Memory has multiple regional
atrophy correlates, including deep gray matter [9], cerebral
cortex volume [8] ,a n dm e d i a lt e m p o r a ll o b ev o l u m e[ 10,
11]. Therefore, it is reasonable to hypothesize that MS
mightimpairattention-mediatedorexecutiveaspectssuchas
encoding and retrieval as well as consolidation and perhaps
even recognition in some circumstances [11, 12]. That is
why we hypothesize that depending on the aﬀected MS brain
region, short-term memory or long-term memory might be
worsened predominantly and independently.
The California Verbal Learning Test: Second Edition
(CVLT-II) [13], which is the revised version of the test
that was initially published in 1987 [14], was selected by
a group of neuropsychologists and neurologists to assess
auditory/verbal memory defects in MS [15]. Benedict and
colleagues [16] recently conﬁrmed the validity of the CVLT-
II with a large cohort of MS data. Of the 23 measures
assessed, 18 signiﬁcantly discriminated MS patients from
demographically matched controls at the conventional P<
.05 threshold, and 14 measures discriminated the groups
at P<. 001. The CVLT-II was able to distinguish2 Multiple Sclerosis International
between groups of healthy participants and MS patients.
A discriminant function analysis of the data retained ﬁve
measures: short delay free recall, recognition discrimination
index, long delay free recall, semantic clustering, retroactive
interference; with 70.0% of the participants correctly classi-
ﬁed [16]. In addition to the conventional CVLT-II measures
available from the test manual and its companion computer
program, Stegen and coauthors [16] used learning measures
derived from a mathematical model based on the ﬁrst-order
transferfunctionfortheassessmentofthelearningcurve[17,
18]. The model’s measures were valid in combination with
someotherCVLT-IIstandardmeasuresindiscriminatingMS
patients from demographically matched controls. However,
Stegen and colleagues did not study whether modeling of the
learning curve of the List A could be used to correctly classify
between groups of healthy participants and MS patients.
Though the CVLT-II provides comprehensive analysis of
short- and long-term memory status, administration of the
standard CVLT-II form takes 30 minutes testing with a 20-
minutedelayinterval[19].Ifexaminationtimeislimitedand
a neuropsychologist requires less detailed information, then
a quick method for assessing memory impairment in MS
patients is needed. Delis and colleagues developed the Cali-
fornia Verbal Learning Test-II Short Form (CVLT-II SF) that
was designed for two purposes: (1) as a cost-eﬀective screen-
ingtooltoidentifymemoryproblemsand(2)toassessverbal
learning and memory without overly taxing patients [13].
However,theCVLT-IISFincludesalistofninewordsinstead
of sixteen. In our opinion, nine words are not enough for
an accurate assessment of long-term memory because many
individuals are able to learn and recall 15-16 words [16].
To assess both short-term and long-term memory, many
MS researchers still rely on the predictive validity of CVLT-
II learning trials 1–5 because on the one hand, it is part of
a consensus battery [15] and, on the other, it is useful as a
standalone free recall test for diagnosis of overall memory
impairment. The latter feature attracts attention because
the time required for clinical assessments of MS patients is
important from both an economic standpoint and avoiding
patientfatigue.PresentationofListAwithoutthesubsequent
subtests (learning of the list B, delay trials, etc.) during
initial examination of a patient lessens the burden on the
patient. If List A does not reveal signiﬁcant overall memory
impairment, then additional memory testing for the patient
under examination may not be required.
The CVLT-II provides standardized scores for each of the
ﬁve learning trials, so that the clinician can assess the con-
sistency of the patient’s immediate-recall performance across
trials. The consistency means that the number of correct
recalled words increases more or less monotonously from
trial to trial. However, frequentlyﬂuctuating emotional state,
incompleteeﬀort,medicationeﬀects,painsymptoms,andso
forth inﬂuence the raw scores. Thus, poor scores on one or
two trials in the face of better recall on the other trials can
lead to an inaccurate assessment of learning and memory.
In this paper, we advocate discriminant analysis in the
evaluation of learning curves. The discriminant analysis
creates a linear combination of predictor variables that
provides the best discrimination between, for example, a
control group of healthy individuals and a group of MS
patients [20]. If the raw scores trials 1–5 are used as predictor
variables, discriminant analysis outputs a multidimensional
linear function y = C0 + C1 ∗ Trial 1 + C2 ∗ Trial 2 + C3 ∗
Trial 3 + C4 ∗Trial 4 + C5 ∗Trial 5 and a boundary value for
this function Yb. A clinician substitutes predictor variables—
Trial 1, Trial 2, and so forth with raw scores trials 1–5—and
calculates a value of the discriminant function y.I fy ≥ Yb,
there is no memory impairment in the patient. If y<Y b,
then the patient needs detailed clinical examination to ﬁnd
the major cause of memory impairment. Thus, a relevant
question arises: what measures of the learning curve should
be used as predictor variables for discriminant analysis. In
ouropinion, mathematicalmodelingofListAlearningcurve
provides two coeﬃcients—B3a n dB4 (see below) that are
better predictors than standard CVLT-II measures Trials 1–5.
Description of Our Mathematical Model. Control theory
deﬁnes the general transfer function as follows [21, 22]. If
we designate an input signal acting upon the system as F
and the output signal (the reaction of the system)—as y,
then the transfer function [1/K] = y/F. If the input signal
i se q u a lt oz e r oa tt i m et<0 and is equal to F at t ≥ 0,
it is called “the step function.” Reaction of the ﬁrst-order
system on the step function is described with the diﬀerential
equation τ ·dy/dt+ y = F/K. The equation can be rewritten
in the form dy/dt = (1/τ) · (F/K − y). Deﬁne yss ≡ F/K.
This is the asymptotic (steady) value of the output signal
at t =∞ . The time constant of the system is deﬁned as τ.
Deﬁne a ≡ 1/τ.T h ed i ﬀerential equation takes the form
dy/dt = a (yss − y). Thus, it is seen that the rate of the
transient process in the ﬁrst-order system is proportional
to the diﬀerence between the asymptotic and current value
of the system’s output signal. The solution of the equation
with initial condition y = y0 at t = 0 gives the function of
exponential type y = (y0 − yss)e−at + yss. The measure of
the rate of the transient process is the time constant (τ) that
reveals how much time is necessary for achievement of 63%
from the diﬀerence between the initial (y0) and asymptotic
(yss) levels of the output signal [21, 22].
We adopted the ﬁrst-order transfer function for model-
ing the learning curves in the form B3 ∗ exp(−B2 ∗ (X −
1)) + B4 ∗ (1 − exp(−B2 ∗ (X − 1))). X is the trial number
and Y is the quantity of correctly recalled words without
repetitions. The parameters are B2—the learning rate; B3—
the value of correctly recalled words on the ﬁrst trial (i.e.,
B3 = Y at X = 1); B4—the asymptotic value of recalled
words at X =∞ .
Using the independent variable in the form of (X − 1)
means that B3 is very close to the CVLT-II Trial 1 standard
measure. The number of correct recalled words on the ﬁrst
trial assesses mainly short-term memory volume [23]. Delis
and colleagues have indicated that “performance on the
ﬁrst immediate-recall trial of List A (Trial 1) is thought to
be especially dependent on auditory attention span” [13,
page 28]. Factors such as motivation [24], general health,
and previous experience with the test might also inﬂuence
the ﬁrst trial recall. Thus, we treat B3 as an estimator ofMultiple Sclerosis International 3
the general functional state of a participant before starting
the test and call it “readiness to learn” [18], hence B3i s
an abbreviation for “readiness to learn.” In our model, B3
primarily represents attention span and short-term memory
encoding process.
Learning in either version of the CVLT begins when the
listofwordsispresentedrepeatedlywithtrial2beingtheﬁrst
repetition. As the developers of the CVLT-II indicate, “When
neurologically intact individuals are provided with addi-
tional opportunities to learn a “supraspan” list of words (i.e.,
a list of words longer than 7 ± 2 words), their recall on the
subsequent trials typically exceeds their auditory attention
span and increases with each new trial.” Thus, encoding into
and retrieval from LTM plays an increasingly greater role in
recall performance with each representation of the same list.
PerformancesonListATrials2to5oftheCVLT-IIreﬂectthe
core verbal learning abilities of the examinee” [13, page 29].
Thus, in our model, B4 predominantly assesses long-term
memory. Other factors such as ﬂuctuating emotional state,
medication eﬀects, pain symptoms, and eﬀort also inﬂuence
B4v a l u e s[ 13]. We treat B4 as an estimator of general ability
to learn and call it “ability to learn” [18]; hence, B4i sa n
abbreviation for “ability to learn”. In our model, B4i sa
measure of long-term memory.
Velocity of learning is characterized by the time constant
that reveals how much trials (after trial 1) are necessary
for achieving 63% from the diﬀerence between B3a n dB4.
Coeﬃcient B2 is inverse value of the time constant, so that
the higher the value of B2 the faster is the learning rate.
Hence, B2 is an abbreviation for “the learning rate.” The
CVLT-II provides a measure of the learning rate in the
form of the learning slope score that is calculated by a least
squaresregressionofthelinearmodelandreﬂectstheaverage
number of newly recalled words per trial. The learning slope
has an important shortcoming. If a person does very well on
trial 1, there tends to be a ceiling eﬀect with little room for a
learningslope.Theslopeissteepwhenapersondoeslesswell
on Trial 1 and then does better in subsequent trials. In such
a situation, the CVLT-II learning slope is misleading when a
person earns a high score on trial one. Generally, from math-
ematical point of view, there might be a correlation between
the CVLT-II learning slope and diﬀerence between maximal
score over all trials (Ymax) and a score on Trial 1 (Y1).
Mathematically, learning slope = a0 + a1 ∗ (Ymax − Y1). We
foundthattheCVLT-IIlearningslopesigniﬁcantlycorrelated
with the diﬀerence between the maximal number of recalled
words and the number of recalled words on trial 1 [25].
Our coeﬃcient B2, reﬂecting the number of trials
needed to reach diﬀerence between B3a n dB4, diﬀers in
principal from the Learning Slope. The Pearson correlation
between B2a n d( Ymax − Y1) is nonsigniﬁcant [25]. In other
words, B2i sm o r er o b u s tr e l a t i v et oah i g hs c o r eo nt r i a l1 .
Nevertheless, we assume that, when comparing the learning
rate between two people, B2 gives reliable information, if
readiness to learn (B3) and ability to learn (B4) are the same
in both people.
At this point in our model construction, the meaning
of B2i sd i ﬃcult to specify. We believe that on the whole
B2 might reﬂect the rate of information transfer from
short-term memory to the hippocampus and the rate at
which the hippocampus can encode new episodic memories.
As the construct validity of B2 is poorly understood, we
focused on B3a n dB4 as possible valid predictor variables
for discriminant analysis.
Previously we applied our mathematical model to the
CVLT learning curve for patients with type 2 diabetes
mellitus [26] and next outlined four procedures that must be
implemented to achieve nearly 100% of correct classiﬁcation
of learning deﬁcits in these patients. These procedures
include (1) dividing participants and patients by gender;
(2) dividing participants and patients by high versus low
recall with previous modeling each individual learning
curve, forming samples of B3a n dB4, and next clustering
healthy participants and MS patients by B3o rB4; (3)
conducting separate discriminant analysis of readiness to
learn (coeﬃcient B3) and ability to learn (coeﬃcient B4);
(4) comparing a sample of healthy participants with high
recall scores, (or with high values of B3o rB4) with a sample
from patients with low recall scores, (or with low values of
B3o rB4). Fulﬁllment of these procedures allows calculating
correct boundary values for B3a n dB4 with discriminant
analysis [26].
Dividing Participants and Patients by Gender. First and
foremost, each group of participants and patients should
be divided by gender because women outperform men
on the CVLT [27]a n dg i r l so u t p e r f o r mb o y so nt h e
CVLT-Children’s version [28]. In particular, women score
signiﬁcantly higher than men do on all immediate free
recall trials, having recalled an average of approximately
one word per trial more than men have. Women use active,
semantically mediated strategies during encoding, whereas
men prefer to recall words in the order in which they were
presented, which is a less eﬀective organizational strategy,
and are more inclined to recall items from the primacy and
recency regions [29].
The diﬀerent encoding strategies among males and
females have an eﬀect on such CVLT/CVLT-II measures
as the Semantic Clustering index and the Serial Clustering
index. A semantic cluster occurs when two words in adjacent
recall positions are members of the same category and a
serial cluster occurs when two words are recalled in the same
sequence in which they presented on the list [14, 30]. In a
group of men and women, matched for age and education,
a mean value of the semantic clustering index was 2.53 for
females versus 1.94 for males (P<. 005), but the serial
clustering index was 1.86 in females versus 2.48 in males
(P<. 05),conﬁrmingthatwomenusemoreeﬃcientmodeof
organization of verbal information on free recall trials than
men [27]. Thus, the CVLT/CVLT-II is constructed with an
initial bias toward women and this bias must be taken into
consideration to optimize modeling of the learning curve. In
addition, gray matter and central atrophy are more advanced
in male MS patients, whereas white matter atrophy is more
advanced in female MS patients [31].
Separate Assessment of B3 and B4. Developers of the CVLT/
CVLT-II/CVLT-C divide learning and memory impairment4 Multiple Sclerosis International
as assessed with List A into three patterns [13]. The ﬁrst
pattern is performed by individuals with impaired attention
but normal learning and memory who may perform poorly
on trial 1 but recoup and perform adequately on subsequent
trials. In our terminology, this pattern stands for insuﬃcient
readiness to learn.
The second pattern may be observed in individuals
with some neurological disorders that damage the memory
circuitryofthebrainbutleaveattentionalprocessesrelatively
intact. These individuals perform in the average or near-
average range on trial 1 but on subsequent trials fail
to assimilate additional information beyond their initial
attention span. In our terminology, this pattern stands for
insuﬃcient ability to learn.
The third pattern is seen in individuals with deﬁciencies
in both attention and learning. These individuals perform
poorly on trial 1 and continue to do so on subsequent
immediate-recall trials. In our terminology, this pattern
stands for insuﬃcient readiness and insuﬃcient ability to
learn. As Delis and colleagues state, “performance on the
immediate-recall trials of the CVLT-II (i.e., the ﬁrst ﬁve
learning trials) usually reﬂects a nebulous combination of
STM and LTM, which precludes precise conclusions about
the relative integrity of these proposed memory systems [13,
page 27].”
Thepurposeofthisstudywastoassesswhichmeasuresof
the learning curve—the standard CVLT-II measures Trials1–
5o rc o e ﬃcients B3a n dB4 of our mathematical model—
must be used as predictor variables for discriminant analysis
between healthy persons and MS patients.
2.MaterialsandMethods
2.1. Participants. Normal controls were ninety-eight healthy
volunteers (78 females and 20 males). A group of MS
patients included 365 patients (266 females and 99 males)
with clinically deﬁned multiple sclerosis [32] being part of a
larger previous study [16]. Throughout the text, the phrase
“healthy participants” represents normal controls, and the
phrase “MS patients” represents participants with clinically
deﬁned multiple sclerosis.
All were at least 18 years of age and ﬂuent in the English
language. Exclusion criteria were (a) presence of a medical
disorder other than MS aﬀecting cognitive function, (b)
psychiatric disorder [33] other than mood, personality, or
behavioral change following the onset of MS, (c) drug or
alcohol dependence or current abuse, (d) motor or sensory
impairment that could compromise testing (e.g., corrected
vision of at least 20/70), and (e) relapse or corticosteroid
treatment within four weeks of assessment.
Prior to participation, all research participants provided
written consent as approved by institutional review boards
andconsentedfortheelectronicstorageoftheirtestdata.The
mean (±SD) age of MS patients was 46.3±9.1 years. Patients
completed 14.2 ± 2.4 years of education. Disease duration
was10.7±8.0 years. The majority were Caucasian (92%) and
female (n = 266 or 72.9%), consistent with MS population
demographics [34]. Disease course was as follows: relapsing
remitting (RR) n = 266 or 72.9%, secondary progressive
(SP) n = 80 or 21.9%, progressive-relapsing n = 9o r2 . 5 % ,
primary progressive n = 10 or 2.7%.
Healthycontrolswithameanageof45.33±7.3and14.6±
1.4 years of education were recruited through newspaper
advertisements, which targeted demographics consistent
with the patient sample. The majority of the controls were
Caucasian and women (n = 78 or 79.6%). The diﬀerences
between the female versus male controls and MS patients
in age or educational level did not reach signiﬁcance using
ANOVA or chi-squared tests. Other details are available
elsewhere [16].
2.2. Procedure. A combined sample of MS patients seen for
research (n = 91, 24.9%), routine clinical monitoring (n =
151, 41.4%), or clinical indication (n = 123, 33.7%) was
used. Research participants (including all normal controls)
werecontactedbymailorwereapproachedduringthecourse
of their usual clinical care at an MS center. Clinical patients
were evaluated for either routine monitoring of cognitive
function or for speciﬁc clinical reasons. Participants were
assessed using the entire MACFIMS battery (the Minimal
Assessment of Cognitive Function in Multiple Sclerosis)
administered individually by a psychologist, trained assis-
tant, or a graduate student under the supervision of a board-
certiﬁed neuropsychologist. All participants were assessed at
aﬃliated hospitals in association with the Department of
Neurology at the State University of New York at Buﬀalo.
2.3. Measures. Representing the auditory/verbal memory
domain, the CVLT-II was administered in the standard
manner [13] as part of the Minimal Assessment of Cognitive
Function in multiple sclerosis protocol [15]. The CVLT-II
assesses memory with two 16-item word lists. The words are
grouped into four semantic categories of four words each.
In general, participants are asked to recall the ﬁrst list (List
A) following each of ﬁve exposures. All details on CVLT-
II standard measures are available elsewhere [16]. For the
purposes of the quantitative analysis of the learning curve,
free recall of 16 words from list A during ﬁve consecutive
trials was used [13].
2.4. Estimation of the Parameters of the Model and Its Veri-
ﬁcation. SPSS and Mathematica were used to estimate the
model’sparameters.Rsquared(R2)wasusedf o rv e riﬁcatio n.
The closer the learning data are to the model values the
higher is R2, its maximal value being equal to 1. A step-
by-step guide to make the calculations using SPSS and
Mathematicaisprovidedinourrecentpapers[18,25,26].To
make the calculations as easy as possible we have, developed
software (“The Learning Curve Modeling Tool”).
2.5. Standard Statistical Methods. SPSS was used for all
statistical calculations. When discriminant analysis was used
with trials 1–5, we checked an option “Enter independents
together” to include each Trial value into calculations.
Hierarchical cluster analysis based on Ward’s method was
used with trials 1–5 measures as variables entered together.Multiple Sclerosis International 5
K-means cluster analysis, which in our case is reduced to two
means, was used with B3o rB4 as a single variable.
3. Results
3.1. Discriminant Analysis with Standard CVLT-II Measures
Trials 1–5. To assess whether the mathematical modeling of
the learning curve based on our model is more sensitive in
detecting memory deﬁcits than standard CVLT-II measures,
weﬁrstcalculatedmeanvaluesforstandardCVLT-IItrials1–
5 for each trial (98 subjects). Means (± SEM) for the healthy
participant group are presented in Table 1,i t e m1 .M e a n s
for the MS patient group (365 subjects) are presented in the
Table 1, item 2. These means were compared for each trial
with independent sample t-test. Signiﬁcant diﬀerence was
found for each trial (P<. 001). Thus, standard CVLT-II
measures—trials 1–5—were used for discriminant analysis
to assess whether the measures could distinguish healthy
participants from MS patients.
3.1.1. Discriminant Analysis for Healthy Participant and
MS Patient Groups. Wilk’s lambda was signiﬁcant, λ =
.894, χ2 = 51.25, P<. 001, indicating that the linear
discriminantfunctionbasedonrawfreerecallscoreswasable
to signiﬁcantly discriminate between healthy participants
and MS patients. A boundary value for the discriminant
functionis .420.Discriminantfunctionyieldedthefollowing
coeﬃcients: y =− 4,774+0.1564 ∗Trial 1−0.040 ∗Trial 2+
0.047 ∗ Trial 3 − 0.04906 ∗ Trial 4 + 0.349 ∗ Trial 5. The
discriminant function correctly predicted 80.6% of healthy
participants and 61.9% of MS patients.
Taking into account that females outperform males
on CVLT [27, 28], we compared each standard CVLT-II
measures—trials 1–5 between males and females. The means
(±S.E.M.) for the group of healthy male participants (20
subjects) are presented in Table 1,i t e m3 .T h em e a n sf o r
female participants (78 subjects) are presented in Table 1,
item 4. These means were compared for each trial with an
independentsamplet-test.Meanvalueforeachtrialishigher
in females (P ≤ .001). The means (±S.E.M.) of male MS
patients (99 subjects) are presented in Table 1,i t e m5 .T h e
means for female patients (266 subjects) are presented in
Table 1, item 6. Mean value of each trial is higher in females
(P ≤ .002). These results conﬁrmed that healthy and MS
femalesoutperformmalesinthenumberofcorrectlyrecalled
words from the CVLT-II List A. Therefore, we performed
discriminant analysis for males and females separately.
3.1.2. Discriminant Analysis for Males. Wilk’s lambda was
signiﬁcant, λ = .893, χ2 = 12.996, P = .023, indicating
that the linear discriminant function based on raw free recall
scores was able to signiﬁcantly discriminate between healthy
male participants and MS male patients. A boundary value
for the discriminant function is .305. Discriminant function
yielded the following coeﬃcients: y =− 2.666 − 0.104 ∗
Trial 1 −0.245 ∗Trial 2 + 0.295 ∗Trial 3 −0.306 ∗Trial 4 +
0.523∗Trial 5.Thediscriminantfunctioncorrectlypredicted
70% of healthy male participants and 61.6% of MS male
patients.
3.1.3. Discriminant Analysis for Females. Wilk’s lambda was
signiﬁcant, λ = .878, χ2 = 44.064, P<. 001, indicating
that linear discriminant function based on raw free recall
scores was able to signiﬁcantly discriminate between healthy
female participants and MS female patients. The boundary
value for the discriminant function is .242. The discriminant
function yielded the following coeﬃcients: y =− 5.378 +
0.20 ∗ Trial 1 + 0.245 ∗ Trial 2 − 0.018 ∗ Trial 3 + 0.011 ∗
Trial 4 + 0.319 ∗ Trial 5. The results show that the discrim-
inant function correctly predicted 78.2% of healthy female
participants and 62.8% of MS female patients.
We compared each standard CVLT-II measures—trials
1–5 between healthy participants and MS patients with
independent sample t-test. In healthy males, mean values
were signiﬁcantly higher in comparison with MS male
patients on Trial 3 (P = .031) and Trial 5 (P = .006).
In healthy females, mean values were signiﬁcantly higher
in comparison with MS male patients on each trial (P ≤
.001). Nevertheless, discriminant analysis based on standard
measures—trials 1–5—could classify less than 70%, when
all participants within a group are used for discriminant
analysis.
To increase discrimination capacity, we further separated
each group (male and female healthy participants and MS
patients) into two samples—one sample with high and the
other sample with low levels of CVLT-II recall scores using
cluster analysis.
3.2. Cluster Analysis of Healthy Participants and MS Patients
Using Standard CVLT-II Measures Trials 1–5
3.2.1. Cluster Analysis of Healthy Male Participants. The
entiregroupwasdividedintotwoclusters:clusterreferringto
lower memory functioning (9 cases) with smaller values, and
cluster referring to higher memory functioning (11 cases)
with larger values (Figure 1(a)). Mean values (±S.E.M.) for
the cluster of lower memory functioning are presented in
Table 1, item 7; values for the cluster of higher memory
functioning are presented in Table 1, item 8. Comparing
meanswithat-testforindependentsamplesrevealedthatthe
cluster of higher memory functioning means were higher in
comparison with the cluster of lower memory functioning
for each trial (P<. 05) with the exception of Trial 3
(P = .075). Thus, cluster associated with higher memory
functioningbettercharacterizedthehealthymalesampleand
was used for further discriminant analysis.
3.2.2. Cluster Analysis of MS Male Patients. The entire group
was divided into two clusters: one referring to lower memory
functioning (46 cases) with smaller values and another
referring to higher memory functioning (53 cases) with
larger values (Figure 1(b)). Mean values (±S.E.M.) of the
clusterrepresentinglowermemoryfunctioningarepresented
in Table 1, item 9 and for cluster referring to higher memory
functioning in Table 1, item 10. Comparing means with6 Multiple Sclerosis International
Table 1: CVLT-II immediate free recall learning data.
No. Name of the group Trial 1
(Mean ± S.E.M.)
Trial 2
(Mean ± S.E.M.)
Trial 3
(Mean ± S.E.M.)
Trial 4
(Mean ± S.E.M.)
Trial 5
(Mean ± S.E.M.)
(1) Healthy participants, total 7.26 ±0.21 10.67 ±0.24 12.22 ±0.23 13.09 ±0.21 13.76 ±0.18
(2) MS patients, total 6.15 ±0.10 9.16 ±0.14 10.46 ±0.15 11.32 ±0.15 11.66 ±0.14
(3) Healthy participants, males 5.90 ±0.45 8.75 ±0.56 10.75 ±0.42 11.55 ±0.47 12.50 ±0.45
(4) Healthy participants, females 7.60 ±0.23 11.17 ±0.24 12.60 ±0.25 13.49 ±0.21 14.08 ±0.18
(5) MS patients, males 5.65 ±0.18 8.15 ±0.25 9.30 ±0.28 10.17 ±0.30 10.42 ±0.30
(6) MS patients, females 6.33 ±0.12 9.53 ±0.16 10.89 ±0.17 11.74 ±0.17 12.12 ±0.16
(7)
Healthy male participants, cluster
referring to lower memory
functioning
4.44 ±0.50 7.44 ±0.53 9.78 ±0.68 10.33 ±0.67 11.00 ±0.60
(8)
Healthy male participants, cluster
referring to higher memory
functioning
6.82 ±0.63 9.82 ±0.81 11.27 ±0.45 12.36 ±0.53 13.55 ±0.34
(9) MS male patients, cluster referring
to lower memory functioning 4.78 ±0.24 6.41 ±0.28 7.20 ±0.28 7.63 ±0.28 8.02 ±0.32
(10) MS male patients, cluster referring
to higher memory functioning 6.40 ±0.21 9.66 ±0.26 11.13 ±0.26 12.38 ±0.25 12.51 ±0.23
(11)
Healthy female participants, cluster
referring to lower memory
functioning
6.82 ±0.29 9.68 ±0.24 10.92 ±0.26 12.24 ±0.25 13.24 ±0.25
(12)
Healthy female participants, cluster
referring to higher memory
functioning
8.35 ±0.31 12.58 ±0.24 14.20 ±0.22 14.68 ±0.20 14.88 ±0.18
(13) MS female patients, cluster referring
to lower memory functioning 5.32 ±0.13 7.73 ±0.15 8.75 ±0.15 9.68 ±0.18 10.29 ±0.17
(14) MS female patients, cluster referring
to higher memory functioning 7.35 ±0.15 11.34 ±0.16 13.02 ±0.13 13.81 ±0.13 13.95 ±0.13
independent sample t-tests revealed that clusters of higher
memory functioning were higher in comparison with cluster
referring to lower memory functioning (P ≤ .001). The
clusteroflowermemoryfunctioningbettercharacterizedMS
male patients and was used for further discriminant analysis.
3.2.3. Cluster Analysis of Healthy Female Participants. The
entiregroupwasdividedintotwoclusters:clusterreferringto
lowermemoryfunctioning(38cases)withsmallervaluesand
the other referring to higher memory functioning (40 cases)
with larger values (Figure 1(c)). Mean values (±S.E.M.)
for the cluster of lower memory functioning are presented
in Table 1, item 11 and for cluster of higher memory
functioning in Table 1, item 12. Comparing means with a
t-test for independent samples revealed that the clusters
of higher memory functioning were higher in comparison
with the cluster of lower memory functioning for each trial
(P ≤ .001). The cluster of higher memory functioning better
characterized healthy female participants and was used for
further discriminant analysis.
3.2.4. Cluster Analysis of MS Female Patients. The entire
group was divided into two clusters: one referring to lower
memory functioning (133 cases) with smaller values and
another, referring to higher memory functioning (133 cases)
with larger values (Figure 1(d)). Mean values (±S.E.M.)
for cluster of lower memory functioning are presented in
Table 1, item 13 and for the cluster of higher memory
functioning presented in Table 1, item 14. Comparing means
with a t-test for independent samples revealed that the
cluster of higher memory functioning means were higher in
comparison with the cluster of lower memory functioning
for each trial (P ≤ .001). Thus, cluster of lower memory
functioning better characterized MS female participants
sample and was used for further discriminant analysis.
3.3. Discriminant Analysis of Trials 1–5 Clusters Referring to
Lower and Higher Memory Functioning
3.3.1. Discriminant Analysis for Male Groups Clusters. The
cluster of higher memory functioning with high recall raw
scoresfromhealthymaleparticipantsandtheclusteroflower
memory functioning with low recall raw scores from MS
male patients were used for discriminant analysis. Wilks’
lambdaλ = .421,χ2 = 45.4,P<. 001indicatedthatthelinear
discriminant function was able to signiﬁcantly discriminate
between healthy male participants and MS male patients.
A boundary value for the discriminant function is 1.459.
Discriminantfunctionyieldedthefollowingcoeﬃcients: y =
−5.123 − 0.16 ∗ Trial 1 + 0.18 ∗ Trial 2 + 0.186 ∗ Trial 3 +
0.115 ∗ Trial 4 + 0.287 ∗ Trial 5. The discriminant function
correctly predicted 100% of healthy male participants andMultiple Sclerosis International 7
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(b) MS male patients
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(c) Healthy female participants
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(d) MS female patients
Figure 1: Cluster analysis of the CVLT-II measures trials 1–5. (a) Healthy male participants, cluster referring to lower memory functioning
(9 cases) and cluster referring to higher memory functioning (11 cases). Comparing the values for every trial with a t-test for independent
samples revealed that the same trial values diﬀered between cluster referring to lower memory functioning and cluster referring to higher
memory functioning (P<. 05) with the exception of Trial 3 (P = .075). (b) MS male patients, cluster referring to lower memory functioning
(46 cases) and cluster referring to higher memory functioning (53 cases). Comparing the values for each of the ﬁve trials with a t-test
for independent samples, revealed signiﬁcant diﬀerences between cluster referring to lower memory functioning and cluster referring to
higher memory functioning for each trial (P ≤ .001). (c) Healthy female participants, cluster referring to lower memory functioning
(38 participants) and cluster referring to higher memory functioning (40 participants). Comparing values for every trial with a t-test for
independent samples revealed that the same trial values diﬀered between cluster referring to lower memory functioning and cluster referring
to higher memory functioning (P<. 001). (d) MS female patients, cluster referring to lower memory functioning (133 patients) and cluster
referring to higher memory functioning (133 patients). Comparing values for every trial with a t-test for independent samples revealed that
the same trial values diﬀered between cluster referring to lower memory functioning and cluster referring to higher memory functioning
(P<. 001). Cluster referring to lower memory functioning—white bar, cluster referring to higher memory functioning—gray bar. Each bar
represents mean ± S.E.M.
100% of male MS patients. Veriﬁcation of the cluster of
lower memory functioning from healthy males revealed that
6 out of 9 cases were classiﬁed as healthy, that is, 66.7% were
correctly classiﬁed. Veriﬁcation of the cluster referring to
higher memory functioning from MS male patients revealed
that 47 out of 53, that is, 88.7% cases were classiﬁed as
healthy.
3.3.2. Discriminant Analysis for Female Groups Clusters. The
cluster of higher memory functioning with high recall raw
scores from healthy female participants and the cluster refer-
ring to lower memory functioning with low recall raw scores
fromMS femalepatients were used fordiscriminant analysis.
Wilks’ lambda λ = .282, χ2 = 213, P<. 001, indicating
that linear discriminant function was able to signiﬁcantly
discriminate between healthy female participants and MS
female patients. A boundary value for the discriminant func-
tion is 1.881. Discriminant function yielded the following
coeﬃcients: y =− 7.326+0.121 ∗Trial 1 + 0.191 ∗Trial 2 +
0.295∗Trial 3+0.114∗Trial 4+0.063 ∗ Trial 5.Thediscrim-
inant function correctly predicted 100% of healthy female
participants and 100% of MS female patients. Veriﬁcation
of the cluster of lower memory functioning from healthy
females revealed that only one out of 38 cases was classiﬁed
as healthy. Veriﬁcation of the cluster of higher memory
functioning from MS female patients revealed that 72 out
of 133, that is, 54.1% cases were classiﬁed as healthy and 61
cases, that is, 45.9% were classiﬁed as MS female patients.8 Multiple Sclerosis International
In summary, ﬁrst dividing participants and patients
by gender and then further dividing them by high versus
low recall using standard CVLT-II measures trials 1–5
substantially improves classiﬁcation of memory impairment
in patients with multiple sclerosis. However, the use of
clustersisnotabletoidentifyclearlyshort-termorlong-term
memory impairment. In the following section, we tested the
ability of our model to identify short-term and long-term
memory impairment in MS patients.
3.3.3. The Averaged Learning Curves of the Trials 1–5 Clusters
Used for Discriminant Analysis. Our mathematical model
allows separate assessment of short-term and long-term
memory, because B3 represents attention span and short-
term memory encoding process, whereas B4 represents
long-term memory consolidation process. Therefore, we
modeled the learning curve for the cluster of lower memory
functioning and the cluster of higher memory functioning
from male and female healthy participants and MS patients.
The learning curves averaged from healthy male par-
ticipants outputted the following values for the model’s
coeﬃcients: for the cluster referring to lower memory
functioning B3 = 4.39 ± 0.29, B4 = 11.69 ± 0.55, and for
the cluster referring to higher memory functioning B3 =
6.90±0.27, B4 = 15.0±1.0. Comparing coeﬃcients revealed
that B3a n dB4d i ﬀered (P = .003 and P = .044 accordingly).
ThelearningcurvesaveragedovereachclusterfromMSmale
patients outputted the following values for the coeﬃcients:
for cluster referring to lower memory functioning B3 =
4.80 ± 0.08, B4 = 8.29 ± 0.14, and for cluster referring
to higher memory functioning B3 = 6.40 ± 0.21, B4 =
13.10 ± 0.34. Comparing the coeﬃcients revealed that B3
and B4d i ﬀered (P = .002 and P = .0002 accordingly).
The learning curves from healthy female participants
outputted the following values for the model’s coeﬃcients:
for the cluster referring to lower memory functioning B3 =
6.90 ± 0.26, B4 = 14.92 ± 1.11, and for the cluster
referring to higher memory functioning B3 = 8.34 ± 0.05,
B4 = 15.01 ± 0.04. Comparing of coeﬃcients revealed that
B3d i ﬀered (P = .006), but B4 did not diﬀer (P>. 2). Here,
clustering with standard measures—trials 1–5 separated
individual cases only by B3, but not B4. The learning
curves averaged over each cluster from MS female patients
outputted the following values for the model’s coeﬃcients:
for the cluster referring to lower memory functioning B3 =
5.36 ± 0.17, B4 = 10.99 ± 0.44, and for the cluster referring
to higher memory functioning B3 = 7.34 ± 0.08, B4 =
14.22±0.09.ComparingthecoeﬃcientsrevealedthatB3and
B4d i ﬀered (P = .0005, and P = .002 accordingly).
Our results suggest that clustering with standard
measures—trials 1–5 separated subjects by B3a n dB4.
Figure 2 illustrates that clustering of raw recall scores did not
distinguish between B3a n dB4 due to considerable overlap
between the cluster of lower memory functioning and the
cluster of higher memory functioning in healthy participants
and MS patients. This overlap suggests the possibility of
obtaining misleading information on the level of readiness
to learn and ability to learn. Thus, modeling of the learning
curve might be necessary to distinguish between short-term
and long-term impairment in MS patients.
3.4. Use of Coeﬃcients B3 and B4 as Predictor Variables
for Discriminant Analysis. In the next sections, we present
results of the use of coeﬃcient B3a n dB4 for discriminant
analysis.
3.4.1. The Averaged Learning Curve of Healthy Participants.
The averaged learning curve of all healthy participants
(Table 2,item1),the78femaleparticipants (Table 2,it e m2),
and the 20 male participants (Table 2,i t e m3 )p r o v i d e dg o o d
ﬁts with our model based on very high values of R-squared.
Comparison of the coeﬃcients revealed that B3w a sh i g h e r
in females (P = .0016). Other coeﬃcients did not diﬀer
(P = .075 for B2a n dP = .20 for B4). The averaged learning
curve of females (Figure 3, empty triangles) was positioned
above the curve for males (Figure 3, empty down triangles).
3.4.2. The Averaged Learning Curve of MS Patients. The
averaged learning curve sampled from MS patients also
diﬀered between men and women. The averaged curve of
a l lM Sp a t i e n t s( Table 2, item 4), 266 female MS patients
(Table 2, item 5), and 99 male MS patients (Table 2,i t e m6 )
provided good ﬁts with our model based on very high values
of R-squared. Coeﬃcient B3( P = .006) and coeﬃcient B4
(P = .002) was higher in MS female patients (Figure 3,ﬁ l l e d
triangles) in comparison with MS male patients (Figure 3,
ﬁlled down triangles). The coeﬃcient B2 did not diﬀer (P =
.32).
3.4.3. Comparison of the Averaged Learning Curve of Healthy
ParticipantsandMS Patients. The averagedlearning curve in
MS patients diﬀers signiﬁcantly from the averaged learning
curve in healthy participants both for the total learning
data and for learning data of females or males calculated
separately.Comparisonoftheaveragedlearningcurveforthe
group of healthy participants (Table 2, item 1) and the group
of MS patients (Table 2, item 4) revealed that B3( P = .002)
andB4(P = .001)werehigherinhealthyparticipantsthough
B2 did not diﬀer (P = .56). The averaged learning curve for
healthy participants was positioned nearly in parallel above
the averaged learning curve for MS patients.
Separate comparison of healthy female participants
(Table 2, item 2) with female MS patients (Table 2,i t e m5 )
revealed lower values of B3( P = .0019) and B4( P =
.0018) in female MS patients with no diﬀerence between B2
(P = .88). The averaged learning curve for healthy female
participants was positioned above the averaged learning
curve for female MS patients (see Figure 3).
Unlike females, comparison of healthy male participants
(Table 2, item 3) with male MS patients (Table 2,i t e m6 )
revealed that B2( P = .13) and B3( P = .29) were not
aﬀected, but B4 was higher in healthy male participants (P =
.006). Both learning curves practically coincide at trial 1 (see
Figure 3). Coeﬃcient B3( P = .006) and B4( P = .002) was
higher in MS female patients in comparison with MS male
patients.Multiple Sclerosis International 9
Table 2: Values of the Model’s coeﬃcients for the averaged learning curves.
No Group
Model’s coeﬃcients ± asymptotic standard error
R2
B2 B3 B4
(1) All healthy participants 0.65 ±0.06 7.28 ±0.13 14.17 ±0.22 0.9987
(2) Female healthy participants 0.70 ±0.07 7.63 ±0.15 14.38 ±0.23 0.9982
Signiﬁcance level, P 0.075 0.0016 0.20
(3) Male healthy participants 0.47 ±0.06 5.90 ±0.17 13.58 ±0.48 0.9978
(4) All MS patients 0.70 ±0.04 6.16 ±0.09 12.01 ±0.13 0.9992
(5) Female MS patients 0.72 ±0.04 6.35 ±0.09 12.44 ±0.13 0.9993
Signiﬁcance level, P 0.32 0.006 0.002
(6) Male MS patients 0.64 ±0.06 5.66 ±0.10 10.86 ±0.17 0.9987
(7) Male healthy participants, cluster referring to lower
memory functioning using B3w i t hl o wv a l u e s 0.4407± 0.0902 3.91 ±0.30 13.72 ±0.95 0.9956
Signiﬁcance level, P 0.68 0.002 0.85
(8) Male healthy participants, cluster referring to higher
memory functioning using B3 with high values 0.5274 ±0.177 7.5 ±0.36 13.46 ±0.85 0.9850
(9) Male healthy participants, cluster referring to lower
memory functioning using B4w i t hl o wv a l u e s 1.1353 ±0.3044 4.38 ±0.42 9.96 ±0.37 0.9838
Signiﬁcance level, P 0.06 0.01 0.0007
(10) Male healthy participants, cluster referring to higher
memory functioning using B4 with high values 0.3361 ±0.0317 6.39 ±0.09 15.76 ±0.49 0.9994
(11) Male MS patients, cluster referring to lower memory
functioning using B3w i t hl o wv a l u e s 0.6505 ±0.0344 4.26 ±0.06 9.81 ±0.11 0.9995
Signiﬁcance level, P 0.73 0.00006 0.002
(12) Male MS patients, cluster referring to higher
memory functioning using B3 with high values 0.6179 ±0.0821 6.97 ±0.14 11.85 ±0.25 0.9971
(13) Male MS patients, cluster referring to lower memory
functioning using B4w i t hl o wv a l u e s 0.8192 ±0.0252 5.17 ±0.03 8.74 ±0.03 0.9998
Signiﬁcance level, P 0.044 0.013 0.0014
(14) Male MS patients, cluster referring to higher
memory functioning using B4 with high values 0.5087 ±0.1041 6.37 ±0.28 14.21 ±0.69 0.9946
(15) Female healthy participants, cluster referring to
lower memory functioning using B3w i t hl o wv a l u e s 0.7231 ±0.0807 5.27 ±0.24 14.28 ±0.34 0.9976
Signiﬁcance level, P 0.75 0.00025 0.72
(16)
Female healthy participants, cluster referring to
higher memory functioning using B3 with high
values
0.6877 ±0.064 8.56 ±0.12 14.43 ±0.19 0.9984
(17) Female healthy participants, cluster referring to
lower memory functioning using B4w i t hl o wv a l u e s 2.0767 ±3.6190 6.98 ±1.44 10.81 ±0.92 0.7277
Signiﬁcance level, P 0.72 0.66 0.017
(18)
Female healthy participants, cluster referring to
higher memory functioning using B4 with high
values
0.6616 ±0.0855 7.67 ±0.20 14.63 ±0.33 0.9971
(19) MS female patients, cluster referring to lower
memory functioning using B3w i t hl o wv a l u e s 0.6286 ±0.0614 5.06 ±0.14 11.62 ±0.24 0.9984
Signiﬁcance level, P 0.024 0.00003 0.0011
(20) MS female patients, cluster referring to higher
memory functioning using B3 with high values 0.8507 ±0.0109 8.08 ±0.02 13.63 ±0.02 0.9999
(21) MS female patients, cluster referring to lower
memory functioning using B4w i t hl o wv a l u e s 0.8642 ±0.0812 5.40 ±0.11 9.88 ±0.13 0.9981
Signiﬁcance level, P 0.084 0.0005 0.00003
(22) MS female patients, cluster referring to higher
memory functioning using B4 with high values 0.6541 ±0.0431 7.01 ±0.11 14.26 ±0.17 0.999210 Multiple Sclerosis International
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(b) MS male group
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
V
a
l
u
e
s
 
o
f
 
c
o
e
ﬃ
c
i
e
n
t
s
 
B
3
 
a
n
d
 
B
4
B3 B4
1
1
2
2
(c) Healthy female group
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
V
a
l
u
e
s
 
o
f
 
c
o
e
ﬃ
c
i
e
n
t
s
 
B
3
 
a
n
d
 
B
4
B3 B4
1
1
2
2
(d) MS female group
Figure 2: Overlapping of B3o rB4 values between clusters after clustering CVLT-II measures trials 1–5. (a) Healthy male group; (b) MS
male group; (c) Healthy female group; (d) MS female group. 1 is the range of the cluster referring to lower memory functioning; 2 is the
range of the cluster referring to higher memory functioning. Identiﬁcation of coeﬃcients is given on the abscissa. This ﬁgure illustrates that
clustering of raw recall scores does not allow distinguishing between B3a n dB4 due to considerable overlapping of each coeﬃcient’s values
between cluster referring to lower memory functioning and cluster referring to higher memory functioning from healthy participants and
MS patients.
Our results supported the existence of CVLT-II gender
bias in favor of females as it was previously shown for CVLT
[27]. The existence of a gender bias necessitates that the
discriminant and cluster analyses be performed separately
for males and females, if our model is to provide greater
precision with respect to identifying memory impairment
in patients with multiple sclerosis and ensure close to 100%
correct classiﬁcation relative to other CVLT-II measures.
3.5. Cluster Analysis of Healthy Male Participants and MS
Male Patients Using Coeﬃcients B3 or B4. Previous to
performing cluster analysis, we modeled each individual
learning curve and formed samples of B3a n dB4. Next,
we clustered healthy participants and MS patients by B3o r
B4. Then, the raw recall scores—trials 1–5 of participants
and patients from each cluster—were used to calculate the
averaged learning curves.Multiple Sclerosis International 11
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Figure 3: The averaged learning curves over all healthy participants
and MS patients. Empty triangles—Healthy female participants; B2
= 0.70; B3 = 7.63; B4 = 14.38. Filled triangles—MS female patients;
B2 = 0.72; B3 = 6.35; B4 = 12.44. Empty down triangles—Healthy
male participants; B2 = 0.47; B3 = 5.90; B4 = 13.58. Filled down
triangles—MS male patients; B2 = 0.64; B3 = 5.66; B4 = 10.86. B3i s
higher in healthy females versus healthy males (P = .0016). B3( P =
.0019) and B4( P = .0018) is higher in healthy female participants
versus MS female patients. B4 is higher in healthy male participants
versus MS male participants (P = .006). B3( P = .006) and B4
(P = .002) is higher in MS female patients in comparison with MS
male patients.
3.5.1. Healthy Male Participants: Clustering Using B3 Only.
Clustering using B3 separated all cases into two clusters:
one cluster of lower memory functioning with low values
of B3 in the range of 2.18 to 5.0 for 9 male participants
and cluster referring to higher memory functioning with
high values of B3i nt h er a n g eo f5 . 9 7t o9 . 0f o r1 1m a l e
participants (Figure 4(a)). Values of the model’s coeﬃcients
are given in Table 2,i t e m s7a n d8 .T h ev a l u eo fB3 is higher
(P = .002) in the cluster associated with higher memory
functioning. The averaged learning curve for the cluster of
higher memory functioning is shown in Figure 5,e m p t y
circles. The cluster of higher memory functioning values
better characterized the healthy male sample and was used
for further discriminant analysis.
3.5.2. Healthy Male Participants: Clustering Using B4 Only.
Clustering using B4 also separated all cases into two clusters:
one referring to lower memory functioning with low values
of B4 in the range 9.71 to 11.31 for 5 male participants
and a cluster referring to higher memory functioning with
high values of B4 in the range 12.24 to 16.73 for 15 male
participants (Figure 4(b)). Values of the model’s coeﬃcients
are in Table 2, items 9 and 10. Coeﬃcient B3a n dc o e ﬃcient
B4 was higher (P = .01 and P = .0007, resp.) in the cluster of
higher memory functioning compared to the cluster of lower
memory functioning. The averaged learning curve for higher
memory functioning is shown in Figure 5, empty diamonds.
Comparison of the coeﬃcients in the higher memory cluster
using B3 and using B4 revealed that B3 was higher (P =
.04) in the cluster of higher memory functioning using B3.
Thus, cluster referring to higher memory functioning values
better characterized the healthy male sample and was used
for further discriminant analysis.
3.5.3. MS Male Patients: Clustering Using B3 Only. Clus-
tering using B3 separated all cases into two clusters: one
referring to lower memory functioning with low values of B3
inthe range0.99to5.22for48 MSmalepatients andanother
referring to higher memory functioning with high values
of B3 in the range 5.64 to 10.02 for 51 MS male patients
(Figure 4(c)). Values of the model’s coeﬃcients are given in
Table 2, items 11 and 12. The value of B3( P = .00006)
and B4( P = .002) was higher in the cluster referring to
higher memory functioning. The averaged learning curve for
the cluster referring to lower memory functioning is shown
in Figure 5, ﬁlled circles. Though MS male patients were
separated using B3, these patients also revealed low value
of B4. Thus, cluster referring to lower memory functioning
better characterized the MS male sample and was used for
further discriminant analysis.
3.5.4. MS Male Patients: Clustering Using B4 Only. Clus-
tering using B4 separated all cases into two clusters: one
referring to lower memory functioning with low values of
B4 in the range of 3.95 to 12.35 for 59 MS male patients
and one referring to higher memory functioning with high
values of B4 in the range of 12.85 to 16.43 for 40 MS male
patients (Figure 4(d)). Values of the model’s coeﬃcients are
given in Table 2, items 13 and 14. The value of B3( P = .013)
and B4( P = .0014) was higher in cluster of higher memory
functioning. Clustering based on coeﬃcient B4 separated
the group of MS male patients into two diﬀerent clusters.
The averaged learning curve for the cluster of lower memory
functioning is shown in Figure 5, ﬁlled diamonds. Though
MSmale patients were separated using B4, coeﬃcient B3w a s
also impaired to some extent. Comparison of the coeﬃcients
between the cluster of lower memory functioning using B3
and B4 revealed that B3 was higher in the cluster of lower
memory functioning using B4( P = .0002). However, B4
was higher in the cluster of lower memory functioning using
B3( P = .0008). Thus, cluster referring to lower memory
functioning better characterized the MS male sample and
was used for further discriminant analysis.
3.6. Discriminant Analysis of the Cluster of Higher Memory
Functioning for Healthy Male Participants and the Cluster of
Lower Memory Functioning for MS Male Patients. Cluster
analysis allowed separating healthy participants with high
values of B3o rB4 and MS patients with low values of the
same coeﬃcients using B3o rB4. Both coeﬃcients (B3, P =
.0009 and B4, P = .013) diﬀered signiﬁcantly between the
cluster referring to higher memory functioning for healthy
males and the cluster referring to lower memory functioning
for MS males using B3. B3( P = .0002) and B4( P =
.0001)alsodiﬀeredsigniﬁcantlybetweentheclusterofhigher
memory functioning in healthy males and the cluster of
lower memory functioning for MS males using B4. We now
use discriminant analysis on these clusters.12 Multiple Sclerosis International
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(a) Healthy male participants, B3
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(b) Healthy male participants, B4
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(c) MS male patients, B3
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(d) MS male patients, B4
Figure 4: Cluster analysis using B3o rB4 in males. (a) Healthy male participants: clustering using B3 only, cluster referring to lower memory
functioning (9 cases) and cluster referring to higher memory functioning (11 cases). There is no overlap between these B3 clusters. (b)
Healthy male participants: clustering using B4 only, cluster referring to lower memory functioning (5 cases) and cluster referring to higher
memoryfunctioning(15cases).ThereisnooverlapbetweentheseB4clusters.(c)MSmalepatients:clusteringusingB3only,clusterreferring
to lower memory functioning (48 cases) and cluster referring to higher memory functioning (51 cases). There is no overlap between these
B3 clusters. (d) MS male patients: clustering using B4 only, cluster referring to lower memory functioning (59 cases) and cluster referring to
highermemoryfunctioning(40cases).Thereisnooverlapbetweenthese B4clusters.Clusterreferringtolowermemoryfunctioning—white
bars, cluster referring to higher memory functioning—gray bars. Each bar represents mean ± S.E.M.
3.6.1. Discriminant Analysis Using B3 Only. First, discrim-
inant analysis was conducted to assess whether coeﬃcient
B3 only could distinguish the cluster of higher memory
functioning for healthy male participants from the cluster
of lower memory functioning for MS male patients. Wilk’s
lambda was signiﬁcant, λ = .406, χ2 = 50.958, P<
.001, indicating that B3 only was able to signiﬁcantly
discriminate between the two groups. The boundary value
for the discriminant function is .958. Discriminant function
yielded the following coeﬃcients: y =− 4.518 + 0.937 ∗
B3. The discriminant function correctly predicts 100% of
healthy participants and 100% of MS patients. The quality
of the discrimination was assessed with the cluster of lower
memory functioning (low B3 values) using B3 for healthy
males. Discriminant function values for all 9 of 9 cases were
less than 0.958. We also assessed the quality of the cluster of
higher memory functioning (high B3 values) for MS male
patients. Here, only one patient with B3 = 5.64 was classiﬁed
as belonging to the MS group, but 50 out of 51 patients
were correctly classiﬁed as belonging to the healthy group.
Thus, 98.0% of participants were classiﬁed with our model
correctly.
3.6.2. Discriminant Analysis Using B4 Only. Discriminant
analysis was also conducted to assess whether coeﬃcient
B4 only could distinguish between the cluster of higher
memory functioning for healthy male participants from the
cluster of lower memory functioning for MS male patients.
Wilk’s lambda was signiﬁcant, λ = .534, χ2 = 44.820,
P<. 001, indicating that the model using B4o n l yw a s
able to successfully discriminate between the two groups.
The boundary value for the discriminant function is .681.
Discriminantfunctionyieldedthefollowingcoeﬃcients: y =
−4.923+0.466∗B4.Theseresultsshowthatthediscriminant
function correctly predicts 100% of healthy participants (15
of 15) and 91.5% of MS patients (54 of 59). Five cases
from the cluster of lower memory functioning using B4
for MS males with B4 values from 12.11 to 12.35 were
classiﬁed as belonging to the healthy group. Thus, 93.2% of
original grouped cases are correctly classiﬁed. The qualityMultiple Sclerosis International 13
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Figure 5: The averaged learning curves over cluster referring to
lower memory functioning and cluster referring to higher memory
functioning for healthy male participants and MS male patients,
using B3o rB4. Empty circles—cluster referring to higher memory
functioning using B3 in healthy male participants; B2 = 0.53; B3
= 7.50; B4 = 13.46. Empty diamonds—cluster referring to higher
memory functioning using B4 in healthy male participants; B2 =
0.34; B3 = 6.39; B4 = 15.76. Filled circles—cluster referring to lower
memory functioning using B3i nM Sm a l ep a t i e n t s ;B2 = 0.65;
B3 = 4.26; B4 = 9.81. Filled diamonds—cluster referring to lower
memory functioning using B4 in MS male patients; B2 = 0.82; B3 =
5.17; B4 = 8.74. In healthy male participants, B3 is higher in cluster
referring to higher memory functioning using B3( P = .04) in
comparison with cluster referring to higher memory functioning
using B4. In MS patients, B3 was higher in cluster referring to
lower memory functioning using B4( P = .0002). However, B4w a s
higher in cluster referring to lower memory functioning using B3
(P = .0008).
of the discrimination was assessed with the cluster of lower
memory functioning (low B4 values) using B4 for healthy
males. Discriminant function values for each of the 5 cases
were less than 0.681 representing 100% correct classiﬁcation.
Next,thequalityoftheclusterofhighermemoryfunctioning
(high B4 values) was assessed for MS male patients. All 40
of 40 patients were classiﬁed as belonging to healthy group
correctly. Thus, 100% are correctly classiﬁed.
3.7. Cluster Analysis of Healthy Female Participants and MS
Female Patients with B3 or B4. Previous to conducting the
cluster analysis, we modeled each individual learning curve
a n df o r m e ds a m p l e so fB3a n dB4. Next we clustered healthy
participants and MS patients by B3o rB4. Then, the raw
recall scores—trials 1–5 of participants and patients from
each cluster were used to calculate the averaged learning
curves.
3.7.1. Healthy Female Participants: Clustering Using B3 Only.
Clustering using B3 alone separated all cases into two
clusters: one referring to lower memory functioning with
low values of B3 in the range of 3.81 to 6.08 for 22
female participants and another referring to higher memory
functioning with high values of B3 in the range of 6.8 to
12.82 for 56 female participants (Figure 6(a)). Values of the
model’scoeﬃcientsareinTable 2,items15and16.Thevalue
of B3i sh i g h e r( P = .00025) in the cluster of higher memory
functioning.Averagedlearningcurvefortheclusterofhigher
memory functioning using B3 is shown in Figure 7,e m p t y
circles. Clustering using B3 separated the group of healthy
female participants into two distinct B3 clusters. Thus, the
cluster referring to higher memory functioning values better
characterized the healthy female sample and was used for
further discriminant analysis.
3.7.2. Healthy Female Participants: Clustering Using B4 Only.
Clustering using B4 alone separated all cases into two
clusters: one referring to lower memory functioning with
low values of B4 in the range of 9.58 to 11.51 for 3
female participants and another referring to higher memory
functioning with high values of B4 in the range of 12.65 to
16.91 for 75 female participants (Figure 6(b)). Values of the
model’scoeﬃcientsaregiveninTable 2,items17and18.The
value of B4i sh i g h e r( P = .017) in the cluster associated with
higher memory functioning. Averaged learning curve for the
cluster of higher memory functioning using B4i sp r o v i d e d
in Figure 3, empty diamonds. In healthy female participants,
B3 is higher in the cluster of higher memory functioning
using B3( P = .019) in comparison with the cluster of higher
memory functioning using B4. Thus, the cluster of higher
memory functioning better characterized the healthy female
sample and was used for further discriminant analysis.
3.7.3. MS Female Patients: Clustering Using B3 Only. Clus-
tering using B3 separated all cases into two clusters: one
referring to lower memory functioning with low values of
B3 in the range of 1.0 to 6.22 for 152 female participants
and another referring to higher memory functioning with
high values of B3i nt h er a n g eo f6 . 6 7t o1 3 . 0f o r1 1 4
female participants (Figure 6(c)). Values of the model’s
coeﬃcients are given in Table 2, items 19 and 20. Here,
clustering was performed using B3 alone, but nevertheless,
both the B3v a l u e( P = .00003), and the B4v a l u e( P =
.0011) was higher in the cluster referring to higher memory
functioning. The averaged learning curve for the cluster of
lower memory functioning using B3 is shown in Figure 7,
ﬁlled circles. Though MS female patients were separated
using B3, the value of B4 was also low. Thus, the cluster of
lower memory functioning values better characterized the
MS female sample and was used for further discriminant
analysis.
3.7.4. MS Female Patients: Clustering Using B4 Only. Clus-
tering using B4 separated all cases into two clusters: one
referring to lower memory functioning with low values of B4
in the range of 4.0 to 12.83 for 109 MS female patients and
another referring to higher memory functioning with high
values of B4 in the range of 12.98 to 16.99 for 157 MS female
patients (Figure 6(d)). Values of the model’s coeﬃcients are
given in Table 2, items 21 and 22. Despite the fact that here
clustering was performed using B4 only, both the B3v a l u e
(P = .0005), and the B4v a l u e( P = .00003) was higher in the
clusterofhighermemoryfunctioning.Theaveragedlearning14 Multiple Sclerosis International
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(a) Healthy female participants, B3
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(b) Healthy female participants, B4
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(c) MS female patients, B3
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(d) MS female patients, B4
Figure 6: Cluster analysis using B3o rB4 in females. (a) Healthy female participants: clustering using B3 only, cluster referring to lower
memoryfunctioning (22 cases) and cluster referring to higher memory functioning (56 cases). There is nooverlap between these B3 clusters.
(b) Healthy female participants: clustering using B4 only, cluster referring to lower memory functioning (3 cases) and cluster referring to
higher memory functioning (75 cases). There is no overlap between these B4 clusters. (c) MS female patients: clustering using B3o n l y ,
cluster referring to lower memory functioning (152 cases) and cluster referring to higher memory functioning (114 cases). There is no
overlap between these B3 clusters. (d) MS female patients: clustering using B4 only, cluster referring to lower memory functioning (109
cases) and cluster referring to higher memory functioning (157 cases). There is no overlap between these B4 clusters. Cluster referring to
lower memory functioning—white bars, cluster referring to higher memory functioning—gray bars. Each bar represents mean ± S.E.M.
curve for the cluster of lower memory functioning using B3
is provided in Figure 7, ﬁlled diamonds. Though MS female
patients were separated using B4, the value of B3 was also
low. Thus, the cluster of lower memory functioning better
characterized the MS female sample and was used for further
discriminant analysis.
3.8. Discriminant Analysis of the Cluster of Higher Memory
Functioning for Healthy Female Participants and the Cluster of
Lower Memory Functioning for MS Female Patients. Cluster
analysis allowed us to separate healthy participants with high
values of B3o rB4 and MS patients with low values of the
samecoeﬃcientsusingB3orB4.CoeﬃcientB3(P = .00005)
and coeﬃcient B4( P = .0008) diﬀered signiﬁcantly between
the cluster of higher memory functioning for healthy females
and the cluster of lower memory functioning for MS females
using B3. B3( P = .0006) and B4( P = .0002) also
diﬀered signiﬁcantly between the cluster of higher memory
functioning for healthy females and the cluster of lower
memory functioning for MS females using B4. We now use
discriminate analysis on these clusters.
3.8.1. Discriminant Analysis Using B3 Only. First, discrim-
inant analysis was conducted to assess whether coeﬃcient
B3 alone could distinguish the cluster of higher memory
functioning for healthy female participants from the cluster
of lower memory functioning for MS female patients. Wilk’s
lambda was signiﬁcant, λ = .372, χ2 = 202.964, P<
.001, indicating that the model using B3 alone signiﬁcantly
discriminate between the two groups. The boundary value
for the discriminant function is .672. Discriminant function
yielded the following coeﬃcients: y =− 4.923 + 0.827 ∗ B3.
The results show that the discriminant function correctly
predicts 100% of healthy participants and 100% of MS
patients. The quality of the discrimination was assessed for
the cluster of lower memory functioning (low B3v a l u e s )
using B3 for healthy females. The values of the discriminant
function for each of the 22 cases were less than 0.672
indicating that all cases were correctly classiﬁed. Next, theMultiple Sclerosis International 15
16
15
14
13
12
11
10
9
8
7
6
5
C
o
r
r
e
c
t
 
w
o
r
d
s
Trials
12345
Figure 7: The averaged learning curves over cluster referring to
lower memory functioning and cluster referring to higher memory
functioning for healthy female participants and MS female patients,
using B3o rB4. Empty circles—cluster referring to higher memory
functioning using B3 in healthy female participants; B2 = 0.69; B3
= 8.56; B4 = 14.43. Empty diamonds—cluster referring to higher
memory functioning using B4 in healthy female participants; B2
= 0.66; B3 = 7.67; B4 = 14.63. Filled circles—cluster referring to
lower memory functioning using B3i nM Sf e m a l ep a t i e n t s ;B2 =
0.63; B3 = 5.06; B4 = 11.62. Filled diamonds—cluster referring
to lower memory functioning using B4i nM Sf e m a l ep a t i e n t s ;B2
= 0.86; B3 = 5.41; B4 = 9.88. In healthy female participants B3
is higher in cluster referring to higher memory functioning using
B3( P = .019) in comparison with cluster referring to higher
memory functioning using B4. In MS patients B4( P = .003) is
higher in the cluster referring to lower memory functioning using
B3 versus cluster referring to lower memory functioning using B4.
B3( P = .00005) and B4( P = .0008) diﬀers highly signiﬁcant
between cluster referring to higher memory functioning for healthy
females and cluster referring to lower memory functioning for
MS females using B3. Besides B3( P = .0006) and B4( P =
.0002) diﬀers highly signiﬁcant between cluster referring to higher
memory functioning for healthy females and cluster referring to
lower memory functioning for MS females using B4.
quality of discrimination was assessed with the cluster of
higher memory functioning (high B3 values) for MS female
patients. Here, only three patients with B3 values 6.67, 6.69,
and 6.76, respectively, were classiﬁed as belonging to MS
group, but 111 out of 114 patients were correctly classiﬁed as
belonging to the healthy group. Thus, 97.4% were correctly
classiﬁed.
3.8.2. Discriminant Analysis Using B4 Only. Discriminant
analysis was conducted to assess whether coeﬃcient B4a l o n e
could distinguish the cluster of higher memory functioning
for healthy female participants from the cluster of lower
memory functioning for MS female patients. Wilk’s lambda
was signiﬁcant, λ = .301, χ2 = 217.890, P<. 001,
which indicated that B4 alone was able to signiﬁcantly
discriminate between the two groups. The boundary value
for the discriminant function is .285. The discriminant
function yielded the following coeﬃcients: y =− 8.399 +
0.679 ∗ B4. The results show that the discriminant function
correctly predicts 98.7% of healthy participants (74 out of
75) and 99.1% of MS patients (108 out of 109). Thus, 98.9%
of original grouped cases are correctly classiﬁed.
The quality of the discrimination was assessed with
the cluster of lower memory functioning (low B4v a l u e s )
using B4 for healthy female participants. A discriminant
function value for each of the three cases was less than
0.285indicating100%correctclassiﬁcation.Next,thequality
of the discrimination was assessed with the cluster of
higher memory functioning (high B4 values) for MS female
patients. All 157 of 157 patients were classiﬁed correctly as
belonging to healthy group using coeﬃcient B4o n l y .
4. Discussion
The identiﬁcation of memory impairment in multiple scle-
rosis is important in clinical practice. The CVLT-II is useful
for assessing auditory/verbal memory defects in MS patients
[15, 16]. We focused on validation of CVLT-II learning
trials—trials 1–5—because it requires less time than the
full test. We found that these CVLT-II measures contained
suﬃcientinformationonshort-termandlong-termmemory
status and could be used for identiﬁcation of overall memory
impairment in patients with multiple sclerosis. However,
adequacy of discriminant analysis depends on some factors
that must be taken into account.
4.1.DividingParticipantsandPatientsbyGender. Ourresults
conﬁrm that females outperform males in the number of
recalled correct words from the CVLT-II List A. In the group
of healthy participants mean value at each trial is higher in
females (P ≤ .001). In the group of MS patients, mean value
at each trial is also higher in females (P ≤ .002). Modeling
of the learning curve revealed that readiness to learn (B3)
was higher in healthy female participants. Moreover, both
readiness to learn (B3) and ability to learn (B4) were
signiﬁcantly higher in MS female patients in comparison
with MS male patients.
Women score signiﬁcantly higher than men do on all
immediate free recall trials, having recalled an average of
approximately one word per trial more than men. Women
use active, semantically mediated strategies during encoding,
whereas men prefer to recall words in the order in which
they were presented, which is a less eﬀective organizational
strategy [29].
4.2.DividingParticipantsandPatientsbyHighandLowRecall
Scores. Our results conﬁrm previous ﬁndings that cognitive
impairment aﬀects about half of all patients with MS [4–
6, 15, 35]. Cluster analysis revealed that 46 out of 99 MS
male patients and 133 out of 266 MS female patients ﬁt
the cluster associated with lower memory functioning. This
result shows that grouping MS patients into two clusters—
one that refers to lower memory functioning, and the other
associated with higher memory functioning—is ideal for
further calculating valid discriminant functions. Thus, the
cluster of lower memory functioning should be used for
further discriminant analysis.16 Multiple Sclerosis International
We also conﬁrmed our previous results that a sample of
healthy participant might be nonhomogeneous [18, 26]. A
controlsampleofhealthyparticipantsmustﬁrstbeseparated
into clusters prior to performing discriminant analysis. In
t h i ss t u d y ,9o u to f2 0h e a l t h ym a l ep a r t i c i p a n t sa sw e l la s3 8
out of 78 healthy female participants ﬁt the cluster associated
with lower memory functioning. Thus, the cluster of healthy
participantswithhighermemoryfunctioningshouldbeused
for further discriminant analysis.
4.3. Separate Discrimination by Readiness to Learn and Ability
to Learn. Our results show that ﬁrst dividing participants
and patients by gender and then further dividing them by
high versus low recall using standard CVLT-II measures
trials 1–5 substantially improves classiﬁcation of memory
impairment in patients with multiple sclerosis. Correct
classiﬁcation reached 100% cases. However, a serious short-
coming still remains regarding the separate assessment of
short-term or long-term memory impairment. Impairment
of cognitive functioning is correlated with brain atrophy
revealed with MRI [7, 8]. Memory has multiple regional
atrophy correlates, including deep gray matter [9], cerebral
cortex volume [8]a n dm e d i a lt e m p o r a ll o b ev o l u m e[ 10,
11]. Therefore, it is reasonable to hypothesize that MS
diﬀerentially aﬀects multiple aspects of memory, including
attention-mediated or executive aspects such as encoding
and retrieval as well as consolidation and perhaps even
recognition in some circumstances [10–12]. That is why
we hypothesize that, depending on the aﬀected MS brain
region, short-term memory, or long-term memory might
be impaired predominantly and independently. Therefore,
B3, reﬂecting short-term memory, and B4, reﬂecting long-
term memory, should be used as separate independent
variables.
4.4. Discriminant Analysis Using B3 or B4. Prior to cluster
analysis, we modeled each individual learning curve and
formed samples of B3a n dB4. Next, we clustered male and
female healthy participants and MS patients by B3o rB4.
Then, clusters with high B3a n dB4 values from healthy
participants were discriminated against clusters with low
B3a n dB4 values from MS patients. Our results show that
clusterization of B3a n dB4 samples instead of clusterization
standard CVLT-II measures not only gives 100% correct
classiﬁcation as standard Trial 1–Trial 5 measures can do but
allows separate assessments of readiness to learn (B3) and
abilitytolearn(B4)thatthestandardTrial1–Trial5measures
cannot do.
Thus, if an MS male patient achieved B3 < 5.84, it
suggests an impairment in readiness to learn and, if B4 <
12.03, it indicates an impairment in ability to learn. For
females, if an MS patient achieved B3 < 6.76, it indicates
an impairment in readiness to learn and, if B4 < 12.79,
it indicates an impairment in ability to learn. By adjusting
the sample by gender and overall CVLT-II performance, our
method of mathematical modeling correctly classiﬁed 100%
of cases.
5. Conclusions
The CVLT-II learning trials 1–5 allow using the learning
curve for assessment of possible learning and memory
impairment. The CVLT-II provides standardized scores for
each of the ﬁve learning trials, so that the clinician can
compare a patient’s raw trials 1–5 scores with standardized
scores. However, frequently a patient’s raw scores ﬂuctuate
due to diﬀerent factors, so that some of the raw scores are
closetothecorrespondingstandardizedscores,butothersare
below normal values. The CVLT-II does not oﬀer any other
methods for classifying a patient’s learning and memory
status based on the learning curve.
The main objective of our research was to illustrate that
discriminant analysis is the method of choice, especially
if suitable predictor variables are selected. Our results
showed that the best predictor variables are coeﬃcients B3
and B4 of our mathematical model because discriminant
functions, calculated separately for B3a n dB4, allow nearly
100% precision of classiﬁcation. These predictors also allow
identiﬁcation of separate impairment of readiness to learn or
ability to learn, or both.
We believe that modeling of the learning curve oﬀers a
quick and eﬀective method for assessing overall learning and
memory impairment. The use of our mathematical model
not only provides clinicians and researchers with additional
information not possible with standard measures, it also
provides a useful and rapid screening method for detection
of early signs of memory impairment in MS patients.
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